Li2P INSERM UMR 1125
Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde
2017
Publications du Li2P INSERM UMR 1125
2017
Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection.Belmellat. N, Semerano L, Segueni N, Damotte D, Decker P, Ryffel B, Quesniaux V, Boissier MC, Assier E. Front Immunol. 2017 Nov 14;8:1533
Salt, inflammatory joint disease, and autoimmunity. Sigaux J, Semerano L, Favre G, Bessis N, Boissier MC. Joint Bone Spine. 2017 Jun 23. pii: S1297-319X(17)30129-X. doi: 10.1016/j.jbspin.2017.06.003.
Developments with experimental and investigational drugs for axial spondyloarthritis. Clavel G, Boissier MC, Sigaux J, Semerano L. Expert Opin Investig Drugs. 2017 Jul;26(7):833-842. doi: 10.1080/13543784.2017.1337744
Do we need animal models to advance research on inflammatory joint disease? Boissier MC, Bessis N. Joint Bone Spine. 2017 Jul;84(4):381-383
Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments. Clavel G, Moulignier A, Semerano L. Joint Bone Spine. 2017 Dec;84(6):671-675. Doi : 10.1016/j.jbspin.2017.03.002. 2017 Mar 18.
Arthritis models: usefulness and interpretation. Bessis N, Decker P, Assier E, Semerano L, Boissier MC. Semin Immunopathol. 2017 Jun;39(4):469-486. doi: 10.1007/s00281-017-0622-4.
Nutrition and chronic inflammatory rheumatic disease. Semerano L, Julia C, Aitisha O, Boissier MC. Joint Bone Spine. 2017 Oct;84(5):547-552. doi: 10.1016/j.jbspin.2016.10.003.
Developments with experimental and investigational drugs for axial spondyloarthritis. Clavel G, Boissier MC, Sigaux J, Semerano L. Expert Opin Investig Drugs. 2017 Jul;26(7):833-842. doi: 10.1080/13543784.2017.1337744.
Vaccination Is Suitable for Treating Inflammatory Diseases. Assier E, Bessis N, Zagury JF, Boissier MC. Front Pharmacol. 2017 Jan 31;8:6. doi: 10.3389/fphar.2017.00006.
Vitamin D supplementation in patients treated for sarcoidosis: Controversy or consensus? Saidenberg-Kermanac'h N, Valeyre D, Boissier MC. Joint Bone Spine. 2017 Oct;84(5):521-523